Cardinal Health Inc. Chief Executive Officer Jason M. Hollar filed a Form 4 on August 20, 2026, disclosing the sale of Cardinal Health common shares across ten transactions on August 18 and August 19, 2026.

Key Highlights

  • Reporting person: Jason M. Hollar, Chief Executive Officer of Cardinal Health Inc. (NYSE:CAH)
  • Total shares sold: 124,529 common shares disposed of across ten reported transactions over two days
  • Price range: Weighted average sale prices ranged from $233.22 to $237.25 per share across the ten transactions, with individual transaction prices spanning from $232.75 to $238.065
  • Remaining ownership: Following all reported transactions, Hollar directly held 190,603 common shares
  • Transaction codes: All ten transactions were coded "S" (sales) and reported as direct ownership dispositions
  • Weighted averages: Each reported price is a weighted average; the filing states full per-share detail is available upon request to Cardinal Health, any security holder, or SEC staff

Cardinal Health CEO Jason Hollar's August 2026 Share Sales: Transaction Details

According to the filing, Jason M. Hollar sold Cardinal Health common shares in four transactions on August 18, 2026, and six transactions on August 19, 2026. On August 18, the transactions involved 21,407 shares at a weighted average price of $234.56, 29,915 shares at $235.51, 16,208 shares at $236.54, and 12,470 shares at $237.25. Those four sales reduced Hollar's direct holdings from a pre-transaction level to 235,132 shares at the close of August 18 activity, as reported in the filing.

On August 19, 2026, the filing discloses six additional sales: 6,206 shares at a weighted average of $233.22, 3,457 shares at $234.29, 5,704 shares at $235.34, 6,731 shares at $236.46, 16,187 shares at $237.23, and 6,244 shares at $237.88. Each price reported represents a weighted average of multiple transactions executed within specified price ranges, as noted in the filing's footnotes. After all ten transactions, Hollar's directly held position stood at 190,603 common shares, according to the filing.

The filing was signed by Amanda S. Pashi as attorney-in-fact on August 20, 2026. No derivative securities transactions were reported in Table II. The filing does not indicate whether the sales were executed under a Rule 10b5-1 plan, as the corresponding checkbox on the form is not checked.

What Was Disclosed

Cardinal Health's CEO disclosed the sale of 124,529 common shares across ten transactions on August 18 and 19, 2026, at weighted average prices between $233.22 and $237.25, leaving a directly held position of 190,603 shares.